Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Billionaire Tom Sandell Pushing For Sale of SemGroup Corp (SEMG)

Page 1 of 2

Thomas Sandell’s Sandell Asset Management, which owns 445,718 shares of common stock in SemGroup Corp (NYSE:SEMG) responded yesterday to SemGroup’s own response to the open letter Sandell sent them on January 26, and expressed disappointment in the response they received from SemGroup’s board. Sandell Asset Management owns 1.2% of SemGroup’s common shares and has economic exposure to an additional 96,742 shares.

Thomas Sandell

Sandell Asset Management, a New York-based hedge fund, was founded in 1998 by Thomas Sandell, and focuses on investing in lesser-known, mid-market companies that are not as well understood by other investors, believing the risk/reward factor of such investments to be more favorable. Nearly the entirety of their assets under management is devoted to the equity markets, with their equity portfolio as of September 30 holding $938 million in value.

Sandell’s current investment in SemGroup Corp (NYSE:SEMG) (they are a recurrent shareholder of the company), which took place entirely during the third quarter of 2014, now represents one of the largest positions in their relatively small portfolio, at 3.95%. As such, it’s an important investment for the hedge fund, and one they feel very strongly about, as evidenced by their January 26 letter.

In the open letter, they expressed the belief that by shedding unnecessary assets, SemGroup could unlock shareholder value, and bemoaned the fact that despite the expectation from shareholders that this would happen to some extent following the appointment of current CEO Carlin Conner in early 2014, that it appears not to be a priority of Mr. Connor, who outlined a more tentative plan in his November 2014 strategic review that did not contain firm commitments to sell non-core assets. Sandell also suggested that selling the company could maximize shareholder value.

As Sandell pointed out, analysts tend to agree with them on the intrinsic value in SemGroup Corp (NYSE:SEMG)’s business, with price targets typically falling within the $75 to $95 range, well above the stock’s current trading rate of $66.92 in afternoon trading Thursday. RBC Capital initiated coverage of the stock on January 22 with an ‘Outperform’ rating and $75.00 price target. While Zacks did downgrade their rating on the stock to ‘Neutral’ on December 31, they have an $81.80 price target on it. And early in December, Capital One also initiated coverage of the stock, giving it an ‘Overweight’ rating.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!